STATE STREET CORP - SUMMIT THERAPEUTICS INC ownership

SUMMIT THERAPEUTICS INC's ticker is SMMT and the CUSIP is 86627T108. A total of 53 filers reported holding SUMMIT THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.26 and the average weighting 0.0%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of SUMMIT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$4,238,484
-25.1%
2,266,569
+0.6%
0.00%
Q2 2023$5,657,477
+2543.4%
2,253,975
+1743.0%
0.00%
Q1 2023$214,025
-71.4%
122,300
-30.4%
0.00%
Q4 2022$747,150
-2.7%
175,800
-43.9%
0.00%
Q1 2022$768,000
-15.3%
313,401
-7.0%
0.00%
Q4 2021$907,000
-46.1%
337,114
+0.3%
0.00%
Q3 2021$1,684,000
-12.1%
336,198
+31.0%
0.00%
Q2 2021$1,915,000256,7000.00%
Other shareholders
SUMMIT THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Alpine Global Management, LLC 202,928$8620.29%
AWM Investment Company, Inc. 300,000$1,275,0000.18%
Virtus ETF Advisers LLC 42,835$182,0490.10%
Baker Brothers Advisors 2,000,000$8,500,0000.05%
VANCE WEALTH, INC. 13,299$56,5210.04%
Inscription Capital, LLC 17,000$72,2500.02%
Steward Partners Investment Advisory, LLC 305,000$1,296,2500.02%
BOOTHBAY FUND MANAGEMENT, LLC 221,205$940,1210.02%
LEVIN CAPITAL STRATEGIES, L.P. 39,176$166,4980.02%
683 Capital Management, LLC 50,838$216,0620.02%
View complete list of SUMMIT THERAPEUTICS INC shareholders